Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments

被引:63
作者
Owusu, Cynthia [1 ,2 ]
Koroukian, Siran M. [2 ,3 ]
Schluchter, Mark [2 ,3 ]
Bakaki, Paul [2 ,3 ]
Berger, Nathan A. [1 ,2 ]
机构
[1] Univ Hosp Cleveland, Dept Hematol Oncol, Cleveland, OH 44106 USA
[2] Case Comprehens Canc Ctr, Cleveland, OH USA
[3] Case Western Reserve Sch Med, Dept Epidemiol & Biostat, Cleveland, OH USA
关键词
Older; Cancer; Comprehensive Geriatric Assessment; Screening; VES-13; KPS; ECOG-PS; CELL LUNG-CANCER; FUNCTIONAL LIVING INDEX; MINI-MENTAL-STATE; QUALITY-OF-LIFE; PERFORMANCE STATUS; ELDERLY-PATIENTS; PROSTATE-CANCER; SURVIVAL; CHEMOTHERAPY; DISABILITY;
D O I
10.1016/j.jgo.2010.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The Vulnerable Elders Survey (VES-13) has been validated for screening older cancer patients for a Comprehensive Geriatric Assessment (CGA). To identify a widely acceptable approach that encourages oncologists to screen older cancer patients for a CGA, we examined the Eastern Cooperative Oncology Group Performance Status (ECOG-PS) and Karnofsky Index of Performance Status (KPS) scales' ability to identify abnormalities on a CGA and compared the performance of the two instruments with the VES-13. Methods: We enrolled 117 participants, >= 65 years with stage I-IV cancer into this cross-sectional study. Our primary outcome variable was >= two abnormalities on the CGA, (Yes or No). We employed receiver operating characteristic curve analysis to compare the discriminatory abilities of the three instruments to identify >= two abnormalities on the CGA. Results: Of the 117 participants, 43% had >= two abnormalities on the CGA. The VES-13 was predictive of >= two abnormalities on the CGA, area under the curve (AUC). 0.85 [(95% CI: 0.78-0.92); sensitivity =88%, specificity =69%, at cut-off >= 3]. The ECOG-PS and KPS showed similar discriminatory powers, AUC=0.88 [(95% CI: 0.83-0.94); sensitivity =94%, specificity =55%, at cut-off >= 1]; and AUC=0.90 [(95% CI: 0.84-0.96); sensitivity =78%, specificity =91%, at cut-off <= 80%], respectively. Conclusion: The ECOG-PS and KPS were equivalent to the VES-13 in identifying older cancer patients with at least two abnormalities on the CGA. Given that oncologists are already conversant with the KPS and ECOG-PS, these two instruments offer medical oncologists a widely acceptable approach for screening older patients for a CGA. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 50 条
  • [41] Comprehensive geriatric assessment as an indicator of postoperative recovery in older patients with colorectal cancer
    Teraishi, Fuminori
    Shoji, Ryohei
    Kondo, Yoshitaka
    Kagawa, Shunsuke
    Tamura, Rie
    Matsuoka, Yoshikazu
    Morimatsu, Hiroshi
    Mitsuhashi, Toshiharu
    Fujiwara, Toshiyoshi
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (08)
  • [42] Characteristics and treatment options of elderly Chinese patients with cancer as determined by Comprehensive Geriatric Assessment (CGA)
    Kanesvaran, Ravindran
    Wang, Wei
    Yang, Yufei
    Wei, Zhengjun
    Jia, Liqun
    Li, Fang
    Wu, Shikai
    Bai, Chunmei
    Xie, Haiyan
    Zhang, Hongliang
    Yang, Guowang
    Sloane, Richard
    Li, Pingping
    Cohen, Harvey Jay
    JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (02) : 171 - 178
  • [43] Predicting outcome in older patients with cancer: Comprehensive geriatric assessment and clinical judgment
    Versteeg, Kathelijn S.
    Looijaard, Stephanie M. L. M.
    Slee-Valentijn, Monique S.
    Verheul, Henk M. W.
    Maier, Andrea B.
    Konings, Inge R. H. M.
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (01) : 49 - 56
  • [44] Four screening instruments for frailty in older patients with and without cancer: a diagnostic study
    Smets, Ineke H. G. J.
    Kempen, Gertrudis I. J. M.
    Janssen-Heijnen, Maryska L. G.
    Deckx, Laura
    Buntinx, Frank J. V. M.
    van den Akker, Marjan
    BMC GERIATRICS, 2014, 14
  • [45] Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study
    Kenis, C.
    Bron, D.
    Libert, Y.
    Decoster, L.
    Van Puyvelde, K.
    Scalliet, P.
    Cornette, P.
    Pepersack, T.
    Luce, S.
    Langenaeken, C.
    Rasschaert, M.
    Allepaerts, S.
    Van Rijswijk, R.
    Milisen, K.
    Flamaing, J.
    Lobelle, J-P
    Wildiers, H.
    ANNALS OF ONCOLOGY, 2013, 24 (05) : 1306 - 1312
  • [46] Costs of medication in older patients: before and after comprehensive geriatric assessment
    Unutmaz, Gulcin Done
    Soysal, Pinar
    Tuven, Busra
    Isik, Ahmet Turan
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 607 - 613
  • [47] Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review
    Molina-Garrido, Maria-Jose
    Guillen-Ponce, Carmen
    AGING MALE, 2017, 20 (02) : 102 - 109
  • [48] A randomized phase II trial of geriatric assessment and management for older cancer patients
    Puts, Martine T. E.
    Sattar, Schroder
    Kulik, Michael
    MacDonald, Mary Ellen
    McWatters, Kara
    Lee, Katherine
    Brennenstuhl, Sarah
    Jang, Raymond
    Amir, Eitan
    Krzyzanowska, Monika K.
    Joshua, Anthony M.
    Monette, Johanne
    Wan-Chow-Wah, Doreen
    Alibhai, Shabbir M. H.
    SUPPORTIVE CARE IN CANCER, 2018, 26 (01) : 109 - 117
  • [49] A randomized phase II trial of geriatric assessment and management for older cancer patients
    Martine T. E. Puts
    Schroder Sattar
    Michael Kulik
    Mary Ellen MacDonald
    Kara McWatters
    Katherine Lee
    Sarah Brennenstuhl
    Raymond Jang
    Eitan Amir
    Monika K. Krzyzanowska
    Anthony M. Joshua
    Johanne Monette
    Doreen Wan-Chow-Wah
    Shabbir M. H. Alibhai
    Supportive Care in Cancer, 2018, 26 : 109 - 117
  • [50] Validation of the Comprehensive Geriatric Assessment as a Predictor of Mortality in Elderly Glioblastoma Patients
    Lombardi, Giuseppe
    Bergo, Eleonora
    Caccese, Mario
    Padovan, Marta
    Bellu, Luisa
    Brunello, Antonella
    Zagonel, Vittorina
    CANCERS, 2019, 11 (10)